Calcipotriene 0.005 % Topical Solution
RxNorm 308865
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 308865 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: calcipotriene 0.005 % Topical Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Calcipotriene 0.05 mg/ML Topical Solution
(Atom ID: 1405910)
PSNPrescribable
Prescribable Name (PSN):
Calcipotriene 0.005 % Topical Solution
(Atom ID: 6407404)
SYPrescribable
Synonym (SY):
Calcipotriene 0.005 % Topical Solution
(Atom ID: 3027549)
PTPrescribable
Designated preferred name (PT):
Calcipotriol 50 microgram/mL cutaneous solution
(Atom ID: 11435645)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely calcipotriol 50 microgram/1 mL conventional release cutaneous solution (clinical drug)
(Atom ID: 11439402)
Patient Education
Calcipotriene Topical
Calcipotriene is used to treat psoriasis (a skin disease in which red, scaly patches form due to increased production of skin cells on some areas of the body). Calcipotriene is in a class of medications called synthetic vitamin D3 derivatives. It works by slowing the excessive production of skin cells.
[Learn More]
* Please review the disclaimer below.